Electromed Non Current Liabilities Total vs Cash Analysis
ELMD Stock | USD 15.77 0.41 2.53% |
Electromed financial indicator trend analysis is much more than just examining Electromed latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Electromed is a good investment. Please check the relationship between Electromed Non Current Liabilities Total and its Cash accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.
Non Current Liabilities Total vs Cash
Non Current Liabilities Total vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Electromed Non Current Liabilities Total account and Cash. At this time, the significance of the direction appears to have pay attention.
The correlation between Electromed's Non Current Liabilities Total and Cash is -0.83. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Cash in the same time period over historical financial statements of Electromed, assuming nothing else is changed. The correlation between historical values of Electromed's Non Current Liabilities Total and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Electromed are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Non Current Liabilities Total i.e., Electromed's Non Current Liabilities Total and Cash go up and down completely randomly.
Correlation Coefficient | -0.83 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Non Current Liabilities Total
Cash
Cash refers to the most liquid asset of Electromed, which is listed under current asset account on Electromed balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Electromed customers. The amounts must be unrestricted with restricted cash listed in a different Electromed account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Electromed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Electromed current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.At present, Electromed's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 17.06, whereas Tax Provision is forecasted to decline to about 954.9 K.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 25K | 78K | 89.7K | 85.2K | Depreciation And Amortization | 628K | 613K | 705.0K | 669.7K |
Electromed fundamental ratios Correlations
Click cells to compare fundamentals
Electromed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Electromed fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 33.2M | 37.1M | 41.4M | 45.8M | 52.7M | 26.4M | |
Short Long Term Debt Total | 81.2K | 87K | 41K | 161K | 144.9K | 137.7K | |
Other Current Liab | 2.4M | 4.0M | (1.5B) | 6.7M | 6.0M | 6.3M | |
Total Current Liabilities | 3.0M | 4.6M | 7.2M | 8.1M | 9.3M | 9.7M | |
Total Stockholder Equity | 30.2M | 32.4M | 34.2M | 37.7M | 43.3M | 45.5M | |
Property Plant And Equipment Net | 3.9M | 3.7M | 4.7M | 5.7M | 6.5M | 3.9M | |
Net Debt | (10.4M) | (11.8M) | (8.1M) | (7.2M) | (6.5M) | (6.2M) | |
Retained Earnings | 13.7M | 14.9M | 15.8M | 18.8M | 21.6M | 22.7M | |
Accounts Payable | 555.5K | 685K | 1.3M | 1.4M | 1.6M | 795.8K | |
Cash | 10.5M | 11.9M | 8.2M | 7.4M | 8.5M | 5.3M | |
Non Current Assets Total | 5.2M | 5.4M | 6.8M | 8.0M | 9.2M | 5.4M | |
Non Currrent Assets Other | 80.2K | 88K | 120M | 161K | 185.2K | 175.9K | |
Other Assets | 755K | 1.1M | 1.5M | 1.6M | 1.8M | 1.9M | |
Cash And Short Term Investments | 10.5M | 11.9M | 8.2M | 7.4M | 8.5M | 5.3M | |
Net Receivables | 14.1M | 17.4M | 21.3M | 24.6M | 28.3M | 29.7M | |
Common Stock Total Equity | 84.1K | 85.7K | 85K | 86K | 98.9K | 86.6K | |
Common Stock Shares Outstanding | 8.8M | 8.9M | 8.8M | 8.7M | 10.0M | 8.8M | |
Liabilities And Stockholders Equity | 33.2M | 37.1M | 41.4M | 45.8M | 52.7M | 26.4M | |
Non Current Liabilities Total | 8.9K | 54K | 41K | 86K | 77.4K | 73.5K | |
Inventory | 3.1M | 2.1M | 3.2M | 4.2M | 4.9M | 2.5M | |
Other Current Assets | 353.3K | 276K | 2.2M | 1.6M | 1.8M | 1.9M | |
Other Stockholder Equity | 16.5M | 17.4M | 18.3M | 18.8M | 21.6M | 16.1M | |
Total Liab | 3.0M | 4.7M | 7.2M | 8.1M | 9.4M | 5.4M | |
Property Plant And Equipment Gross | 3.8M | 3.6M | 4.7M | 5.7M | 6.5M | 3.9M | |
Total Current Assets | 28.0M | 31.7M | 34.5M | 37.8M | 43.5M | 45.6M | |
Short Term Debt | 30.3K | 72.3K | 33K | 80K | 72K | 68.4K | |
Intangible Assets | 598.4K | 663K | 599K | 605K | 544.5K | 517.3K | |
Common Stock | 84.1K | 85.7K | 85K | 86K | 98.9K | 86.6K | |
Property Plant Equipment | 3.9M | 3.6M | 4.6M | 5.7M | 6.5M | 3.9M | |
Current Deferred Revenue | (72.3K) | (33K) | 1.5B | (80K) | (92K) | (87.4K) | |
Net Tangible Assets | 29.7M | 31.8M | 33.6M | 37.1M | 42.6M | 24.2M | |
Retained Earnings Total Equity | 13.7M | 14.9M | 15.8M | 18.8M | 21.6M | 22.7M | |
Capital Surpluse | 16.5M | 17.4M | 18.3M | 18.8M | 21.6M | 16.7M | |
Net Invested Capital | 30.2M | 32.4M | 34.2M | 37.7M | 43.3M | 32.0M |
Pair Trading with Electromed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Electromed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromed will appreciate offsetting losses from the drop in the long position's value.Moving together with Electromed Stock
0.61 | DHR | Danaher | PairCorr |
Moving against Electromed Stock
0.74 | GH | Guardant Health Financial Report 14th of May 2024 | PairCorr |
0.41 | DNA | Ginkgo Bioworks Holdings Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Electromed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Electromed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Electromed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Electromed to buy it.
The correlation of Electromed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Electromed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Electromed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Electromed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.727 | Earnings Share 0.46 | Revenue Per Share 6.072 | Quarterly Revenue Growth 0.167 | Return On Assets 0.0721 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.